MDxHealth Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	70.19	37.05	22.24	18.46	11.79
Revenue Growth (YoY)	89.43%	66.62%	20.47%	56.64%	-
Cost of Revenue	26.26	17.84	11.68	10.42	11.76
Gross Profit	43.93	19.22	10.56	8.04	0.03
Selling, General & Admin	59.93	49.01	31.37	30.74	33.01
Research & Development	6.38	5.5	5.59	4.54	9
Other Operating Expenses	4.96	2.61	0.45	-0.12	1.2
Operating Expenses	71.26	57.12	37.41	35.17	43.2
Operating Income	-27.33	-37.9	-26.84	-27.12	-43.17
Interest Expense / Income	18.34	6.39	2.17	1.54	0.52
Other Expense / Income	-2.57	-0.24	-0.01	-	-0.01
Pretax Income	-43.1	-44.04	-29	-28.66	-43.68
Income Tax	0	0	0	0	-0.58
Net Income	-43.1	-44.04	-29	-28.66	-43.1
Shares Outstanding (Basic)	27	16	16	16	-
Shares Change	73.36%	-	-	-	-
EPS (Basic)	-16.60	-27.80	-23.80	-34.00	-69.00
EPS (Diluted)	-16.60	-27.80	-23.80	-34.00	-69.00
Free Cash Flow	-24.24	-36.91	-23.44	-20.78	-22.36
Free Cash Flow Per Share	-8.97	-23.66	-15.03	-13.32	-
Gross Margin	62.58%	51.87%	47.50%	43.58%	0.25%
Operating Margin	-38.93%	-102.28%	-120.69%	-146.93%	-366.30%
Profit Margin	-61.40%	-118.86%	-130.41%	-155.27%	-365.72%
Free Cash Flow Margin	-34.54%	-99.60%	-105.42%	-112.57%	-189.75%
EBITDA	-17.9	-32.75	-23.79	-23.79	-39.74
EBITDA Margin	-25.50%	-88.38%	-106.99%	-128.88%	-337.20%
Depreciation & Amortization	6.86	4.91	3.04	3.33	3.42
EBIT	-24.76	-37.66	-26.83	-27.12	-43.16
EBIT Margin	-35.27%	-101.63%	-120.64%	-146.93%	-366.22%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).